Advanced Science, 2024 · DOI: 10.1002/advs.202406398 · Published: September 28, 2024
Spinal cord injuries (SCI) often lead to significant disabilities due to damage to the neurovascular unit. This study explores how specific vascular changes occur after SCI and how to target them for treatment. The research found that traumatic SCI causes pathological vascular remodeling, characterized by enlarged blood vessels, a disrupted blood-spinal cord barrier, and increased extracellular matrix deposition. The study also identified osteopontin (OPN) as a critical factor that contributes to this remodeling. By inhibiting Foxo1 phosphorylation, the researchers mitigated vascular remodeling, which improved axon regeneration and neurological function recovery after SCI.
The findings offer a novel perspective for drug therapies aimed at specifically targeting pathological vasculature after SCI.
Aptamer-liposome-encapsulated small molecule can be developed for vascular therapy. This drug delivery system is designed to specifically target endothelial cells at the injury epicenter of SCI.
Intravenous administration of Apt-LP@Sar reduced fibrotic scar area and significantly promoted neural regeneration and functional recovery in mice post-SCI, showing promising clinical application potential.